DK0561941T3 - N-Substituerede lactamer anvendelige som cholecystokinin-antagonister - Google Patents
N-Substituerede lactamer anvendelige som cholecystokinin-antagonisterInfo
- Publication number
- DK0561941T3 DK0561941T3 DK92901239.1T DK92901239T DK0561941T3 DK 0561941 T3 DK0561941 T3 DK 0561941T3 DK 92901239 T DK92901239 T DK 92901239T DK 0561941 T3 DK0561941 T3 DK 0561941T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted lactams
- cholecystokinin antagonists
- useful
- lactams useful
- cholecystokinin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/626,590 US5202344A (en) | 1990-12-11 | 1990-12-11 | N-substituted lactams useful as cholecystokinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0561941T3 true DK0561941T3 (da) | 1995-03-06 |
Family
ID=24511043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92901239.1T DK0561941T3 (da) | 1990-12-11 | 1991-11-25 | N-Substituerede lactamer anvendelige som cholecystokinin-antagonister |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5202344A (es) |
| EP (1) | EP0561941B1 (es) |
| JP (1) | JPH06503827A (es) |
| AT (1) | ATE116638T1 (es) |
| AU (1) | AU9057191A (es) |
| CA (1) | CA2097517A1 (es) |
| DE (1) | DE69106532T2 (es) |
| DK (1) | DK0561941T3 (es) |
| ES (1) | ES2067322T3 (es) |
| IE (1) | IE62703B1 (es) |
| PT (1) | PT99739A (es) |
| WO (1) | WO1992010476A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE912285A1 (en) * | 1990-07-12 | 1992-01-15 | Black James Foundation | Amino acid derivatives |
| DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US6083943A (en) * | 1993-09-17 | 2000-07-04 | Pfizer Inc | Substituted azaheterocyclecarboxylic acid |
| PT719253E (pt) * | 1993-09-17 | 2004-07-30 | Pfizer | Piperidinas 3-amino-5-carboxi-substituidas e pirrolidinas 3-amino-4-carboxi-substituidas como antagonistas de taquicinina |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
| AU6659298A (en) | 1997-02-18 | 1998-09-08 | Thomas Jefferson University | Compositions that bind to pancreatic cancer cells and methods of using the same |
| CA2346108A1 (en) * | 1998-11-09 | 2000-05-18 | James Black Foundation Limited | Gastrin and cholecystokinin receptor ligands |
| US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
| GB0011095D0 (en) | 2000-05-08 | 2000-06-28 | Black James Foundation | astrin and cholecystokinin receptor ligands (III) |
| US6429190B1 (en) | 2000-12-15 | 2002-08-06 | Pacifichealth Laboratories, Inc. | Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK) |
| US6558690B2 (en) | 2000-12-15 | 2003-05-06 | Pacific Health Laboratories, Inc. | Nutritional composition for improving the efficacy of a lipase inhibitor |
| HUP0402503A2 (hu) * | 2001-10-03 | 2005-03-29 | Ucb, S.A. | Pirrolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények |
| GB0130705D0 (en) * | 2001-12-21 | 2002-02-06 | Glaxo Group Ltd | Chemical compounds |
| WO2004022536A1 (en) * | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| CA2503015A1 (en) | 2002-10-23 | 2004-05-06 | Glenmark Pharmaceuticals Ltd. | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| CA2522023A1 (en) | 2003-04-11 | 2004-10-21 | Glenmark Pharmaceuticals S.A. | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| GB0314373D0 (en) | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| GB0314299D0 (en) | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| JP2006527732A (ja) | 2003-06-19 | 2006-12-07 | グラクソ グループ リミテッド | Ｘａ因子の阻害剤としての３−スルホニルアミノ−ピロリジン−２−オン誘導体 |
| WO2006040652A2 (en) | 2004-10-13 | 2006-04-20 | Glenmark Pharmaceuticals S.A. | Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide |
| CA2591438C (en) | 2004-12-17 | 2014-04-29 | Glenmark Pharmaceuticals S.A. | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| ES2417491T3 (es) | 2004-12-17 | 2013-08-08 | Glenmark Pharmaceuticals S.A. | Novedosos compuestos heterocíclicos útiles para el tratamiento de trastornos inflamatorios y alérgicos |
| FR2913888B1 (fr) * | 2007-03-21 | 2010-01-01 | Jean Pierre Breda | Procede et dispositif d'irradiation par rayonnement d'energie photonique modulee |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8921577B2 (en) * | 2012-07-02 | 2014-12-30 | PNB Vesper Life Sciences Pvt. Ltd. | Cholecystokinin receptor ligands |
| AU2014355887B2 (en) * | 2013-11-28 | 2019-02-07 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| HUE058044T2 (hu) | 2018-03-05 | 2022-06-28 | Bristol Myers Squibb Co | Fenilpirrolidinon-formil peptid 2 receptor agonisták |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3474093A (en) * | 1966-05-03 | 1969-10-21 | American Home Prod | Enamine adducts of n-acyloxy-n-acylaminoacetanilide |
| US4200572A (en) * | 1975-09-03 | 1980-04-29 | Smithkline Corporation | Substituted azetidinones |
| US4085100A (en) * | 1976-11-01 | 1978-04-18 | Smithkline Corporation | Intermediate for dephthaloylation of azetidinone compounds |
| US4260743A (en) * | 1979-12-31 | 1981-04-07 | Gist-Brocades N.V. | Preparation of β-lactams and intermediates therefor |
| US4757068A (en) * | 1984-06-26 | 1988-07-12 | Merck & Co., Inc. | Lactams and bicyclic lactams useful as cholecystokinin antagonists |
-
1990
- 1990-12-11 US US07/626,590 patent/US5202344A/en not_active Expired - Lifetime
-
1991
- 1991-11-25 AT AT92901239T patent/ATE116638T1/de not_active IP Right Cessation
- 1991-11-25 CA CA002097517A patent/CA2097517A1/en not_active Abandoned
- 1991-11-25 JP JP4502321A patent/JPH06503827A/ja active Pending
- 1991-11-25 DE DE69106532T patent/DE69106532T2/de not_active Expired - Fee Related
- 1991-11-25 WO PCT/US1991/008648 patent/WO1992010476A1/en active IP Right Grant
- 1991-11-25 EP EP92901239A patent/EP0561941B1/en not_active Expired - Lifetime
- 1991-11-25 DK DK92901239.1T patent/DK0561941T3/da active
- 1991-11-25 AU AU90571/91A patent/AU9057191A/en not_active Abandoned
- 1991-11-25 ES ES92901239T patent/ES2067322T3/es not_active Expired - Lifetime
- 1991-12-10 PT PT99739A patent/PT99739A/pt not_active Application Discontinuation
- 1991-12-10 IE IE429391A patent/IE62703B1/en not_active IP Right Cessation
-
1992
- 1992-10-29 US US07/968,617 patent/US5314886A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE116638T1 (de) | 1995-01-15 |
| US5314886A (en) | 1994-05-24 |
| DE69106532T2 (de) | 1995-06-08 |
| CA2097517A1 (en) | 1992-06-12 |
| WO1992010476A1 (en) | 1992-06-25 |
| ES2067322T3 (es) | 1995-03-16 |
| IE914293A1 (en) | 1992-06-17 |
| DE69106532D1 (de) | 1995-02-16 |
| IE62703B1 (en) | 1995-02-22 |
| JPH06503827A (ja) | 1994-04-28 |
| EP0561941B1 (en) | 1995-01-04 |
| US5202344A (en) | 1993-04-13 |
| AU9057191A (en) | 1992-07-08 |
| EP0561941A1 (en) | 1993-09-29 |
| PT99739A (pt) | 1992-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0561941T3 (da) | N-Substituerede lactamer anvendelige som cholecystokinin-antagonister | |
| DK0607164T3 (da) | Kondenserede tricykliske nitrogenholdige heterocykliske forbindelser som substans P-receptorantagonister | |
| ES2092113T3 (es) | Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno. | |
| MX9203053A (es) | Derivados de aza nor bornano. | |
| DK0641328T3 (da) | Broforbundne, azabicykliske derivater som substans P-antagonister | |
| DK0833644T3 (da) | Farmaceutisk og diætetiske sammensætninger til forebyggelse og behandling af gastrointestinale sygdomme | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| DE69626981D1 (de) | N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide | |
| DK0711283T3 (da) | Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister | |
| ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| ATE168103T1 (de) | Cholecystokininantagoniste | |
| FI964045A0 (fi) | CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä | |
| ATE236888T1 (de) | N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5- benzodiazepin-3-yl)-3-amide | |
| ATE169002T1 (de) | Polyamidsäure-derivate mit antigastrin wirkung, ihre herstellung und ihre verwendung als arzneimittel |